Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
CN¥ 38.33
Key Takeaways
Risk factor
Very high price volatility
Data is available to registered users only
Data is available to registered users only
Profitability factor
Greatly overvalued vs peers
Data is available to registered users only
Data is available to registered users only
About
Hangzhou Biotest Biotech Co., LTD. engages in the research and development, manufacture, sale, and service of in vitro diagnostic assays and reagents, and equipment in China and Internationally. It offers medical test products for fertility health, oncology, cardiology, inflammation, biochemistry, and various infectious diseases, as well as COVID-19 rapid tests, such as antibody and antigen...
Company Valuation
Considering past and projected metrics, the stock is distinctly 'expensive' compared to its peers. Specifically, the stock is 'expensive' on P/E, overvalued on EV/EBITDA,
Data is available to registered users only
Buy
Sell